Correlation Between Le Travenues and Beta Drugs
Can any of the company-specific risk be diversified away by investing in both Le Travenues and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Le Travenues and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Le Travenues Technology and Beta Drugs, you can compare the effects of market volatilities on Le Travenues and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Le Travenues with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Le Travenues and Beta Drugs.
Diversification Opportunities for Le Travenues and Beta Drugs
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between IXIGO and Beta is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Le Travenues Technology and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Le Travenues is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Le Travenues Technology are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Le Travenues i.e., Le Travenues and Beta Drugs go up and down completely randomly.
Pair Corralation between Le Travenues and Beta Drugs
Assuming the 90 days trading horizon Le Travenues Technology is expected to under-perform the Beta Drugs. But the stock apears to be less risky and, when comparing its historical volatility, Le Travenues Technology is 1.05 times less risky than Beta Drugs. The stock trades about -0.03 of its potential returns per unit of risk. The Beta Drugs is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 71,225 in Beta Drugs on August 27, 2024 and sell it today you would earn a total of 137,265 from holding Beta Drugs or generate 192.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 22.79% |
| Values | Daily Returns |
Le Travenues Technology vs. Beta Drugs
Performance |
| Timeline |
| Le Travenues Technology |
| Beta Drugs |
Le Travenues and Beta Drugs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Le Travenues and Beta Drugs
The main advantage of trading using opposite Le Travenues and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Le Travenues position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.| Le Travenues vs. Easy Trip Planners | Le Travenues vs. Yatra Online Limited | Le Travenues vs. Kingfa Science Technology | Le Travenues vs. Rico Auto Industries |
| Beta Drugs vs. Reliance Industries Limited | Beta Drugs vs. Tata Consultancy Services | Beta Drugs vs. HDFC Bank Limited | Beta Drugs vs. Bharti Airtel Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |